Todd Wood is DermTech’s new Chief Commercial Officer.

Mr. Wood will oversee the Sales and Marketing functions. With 25 years of pharmaceutical and medical device commercialization experience, Mr. Wood has launched multiple market leading products including Juvéderm, Lumigan and Rhofade, and aligned operational execution of brands like Botox. He has experience in building sales infrastructures in start-up organizations as well as restructuring complex transitioning organizations like Allergan’s Eye Care franchise.

“DermTech has created a unique product with a fantastic foundation of science, clinical evidence, and physician and patient value. I see this as an opportunity to have a truly transformative impact on the practice of dermatology,” says Mr. Wood in a news release.

“Todd is a tremendous addition to the DermTech team. His deep expertise in dermatology and new product commercialization will allow us to further expand our position as the leading non-invasive genomics company in the field. Under his leadership we plan to significantly scale our business around our upcoming reimbursement milestones,” says John Dobak, M.D., the CEO of DermTech.